(Q53918457)

English

Radiotherapy followed by high dose busulfan and thiotepa: a prospective assessment of high dose chemotherapy in children with diffuse pontine gliomas.

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/10649264

Radiotherapy followed by high dose busulfan and thiotepa: a prospective assessment of high dose chemotherapy in children with diffuse pontine gliomas. (English)

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/10649264

adaptive radiation therapy

0 references

1 reference

based on heuristic

inferred from title

author name string

Bouffet E

1

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/10649264

Raquin M

2

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/10649264

Doz F

3

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/10649264

Gentet JC

4

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/10649264

Rodary C

5

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/10649264

Demeocq F

6

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/10649264

Chastagner P

7

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/10649264

Lutz P

8

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/10649264

Hartmann O

9

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/10649264

Kalifa C

10

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/10649264

language of work or name

0 references

publication date

1 February 2000

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/10649264

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/10649264

88

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/10649264

3

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/10649264

685-692

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/10649264

Pediatric midbrain tumors: a benign subgroup of brainstem gliomas.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2820000201%2988%3A3%3C685%3A%3AAID-CNCR27%3E3.0.CO%3B2-K

21 January 2018

Surgical indication and technical considerations in the management of benign brain stem gliomas

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2820000201%2988%3A3%3C685%3A%3AAID-CNCR27%3E3.0.CO%3B2-K

21 January 2018

Neuroimaging of primary brainstem gliomas: diagnosis and course

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2820000201%2988%3A3%3C685%3A%3AAID-CNCR27%3E3.0.CO%3B2-K

21 January 2018

Brainstem gliomas in children. A Children's Cancer Group review of 119 cases

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2820000201%2988%3A3%3C685%3A%3AAID-CNCR27%3E3.0.CO%3B2-K

21 January 2018

Hyperfractionated radiation therapy for brain-stem glioma: a phase I-II trial.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2820000201%2988%3A3%3C685%3A%3AAID-CNCR27%3E3.0.CO%3B2-K

21 January 2018

Hyperfractionated radiation therapy in brain stem tumors. Results of treatment at the 7020 cGy dose level of Pediatric Oncology Group study #8495.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2820000201%2988%3A3%3C685%3A%3AAID-CNCR27%3E3.0.CO%3B2-K

21 January 2018

Pre-irradiation chemotherapy and hyperfractionated radiation therapy 66 Gy for children with brain stem tumors. A phase II study of the Pediatric Oncology Group, Protocol 8833.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2820000201%2988%3A3%3C685%3A%3AAID-CNCR27%3E3.0.CO%3B2-K

21 January 2018

Hyperfractionated radiation therapy (72 Gy) for children with brain stem gliomas. A Childrens Cancer Group Phase I/II Trial

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2820000201%2988%3A3%3C685%3A%3AAID-CNCR27%3E3.0.CO%3B2-K

21 January 2018

Outcome of children with brain stem gliomas after treatment with 7800 cGy of hyperfractionated radiotherapy. A Childrens Cancer Group Phase I/II Trial.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2820000201%2988%3A3%3C685%3A%3AAID-CNCR27%3E3.0.CO%3B2-K

21 January 2018

The treatment of brain stem and thalamic gliomas with 78 Gy of hyperfractionated radiation therapy

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2820000201%2988%3A3%3C685%3A%3AAID-CNCR27%3E3.0.CO%3B2-K

21 January 2018

UKCCSG study of accelerated radiotherapy for pediatric brain stem gliomas. United Kingdom Childhood Cancer Study Group

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2820000201%2988%3A3%3C685%3A%3AAID-CNCR27%3E3.0.CO%3B2-K

21 January 2018

Pediatric brain stem gliomas: a review

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2820000201%2988%3A3%3C685%3A%3AAID-CNCR27%3E3.0.CO%3B2-K

21 January 2018

Contemporary chemotherapy issues for children with brainstem gliomas.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2820000201%2988%3A3%3C685%3A%3AAID-CNCR27%3E3.0.CO%3B2-K

21 January 2018

High-dose chemotherapy with marrow reinfusion and hyperfractionated irradiation for children with high-risk brain tumors

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2820000201%2988%3A3%3C685%3A%3AAID-CNCR27%3E3.0.CO%3B2-K

21 January 2018

High-dose melphalan and cyclophosphamide with autologous bone marrow rescue for recurrent/progressive malignant brain tumors in children: a pilot pediatric oncology group study

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2820000201%2988%3A3%3C685%3A%3AAID-CNCR27%3E3.0.CO%3B2-K

21 January 2018

Pilot study of high-dose thiotepa and etoposide with autologous bone marrow rescue in children and young adults with recurrent CNS tumors. The Children's Cancer Group

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2820000201%2988%3A3%3C685%3A%3AAID-CNCR27%3E3.0.CO%3B2-K

21 January 2018

High-dose chemotherapy with autologous stem-cell rescue in patients with recurrent and high-risk pediatric brain tumors

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2820000201%2988%3A3%3C685%3A%3AAID-CNCR27%3E3.0.CO%3B2-K

21 January 2018

Etoposide and thiotepa followed by ABMT (autologous bone marrow transplantation) in children and young adults with high-grade gliomas.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2820000201%2988%3A3%3C685%3A%3AAID-CNCR27%3E3.0.CO%3B2-K

21 January 2018

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2820000201%2988%3A3%3C685%3A%3AAID-CNCR27%3E3.0.CO%3B2-K

21 January 2018

Application of the triangular test to phase II cancer clinical trials

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2820000201%2988%3A3%3C685%3A%3AAID-CNCR27%3E3.0.CO%3B2-K

21 January 2018

Treatment of children with progressive or recurrent brain tumors with carboplatin or iproplatin: a Pediatric Oncology Group randomized phase II study

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2820000201%2988%3A3%3C685%3A%3AAID-CNCR27%3E3.0.CO%3B2-K

21 January 2018

A phase II evaluation of thiotepa in pediatric central nervous system malignancies

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2820000201%2988%3A3%3C685%3A%3AAID-CNCR27%3E3.0.CO%3B2-K

21 January 2018

Phase II evaluation of topotecan for pediatric central nervous system tumors

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2820000201%2988%3A3%3C685%3A%3AAID-CNCR27%3E3.0.CO%3B2-K

21 January 2018

PCNU and recurrent childhood brain tumors

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2820000201%2988%3A3%3C685%3A%3AAID-CNCR27%3E3.0.CO%3B2-K

21 January 2018

Recurrent brainstem gliomas treated with oral VP-16.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2820000201%2988%3A3%3C685%3A%3AAID-CNCR27%3E3.0.CO%3B2-K

21 January 2018

Chemotherapy of pediatric brain-stem tumors

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2820000201%2988%3A3%3C685%3A%3AAID-CNCR27%3E3.0.CO%3B2-K

21 January 2018

[HIT-GBM: multicenter study of treatment of children with malignant glioma]

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2820000201%2988%3A3%3C685%3A%3AAID-CNCR27%3E3.0.CO%3B2-K

21 January 2018

High dose chemotherapy with autologous bone marrow rescue for children with diffuse pontine brain stem tumors. Children's Cancer Group

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2820000201%2988%3A3%3C685%3A%3AAID-CNCR27%3E3.0.CO%3B2-K

21 January 2018

Pediatric brainstem glioma. Post-radiation clinical and MR follow-up.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2820000201%2988%3A3%3C685%3A%3AAID-CNCR27%3E3.0.CO%3B2-K

21 January 2018

Acute neurologic dysfunction associated with high-dose chemotherapy and autologous bone marrow rescue for primary malignant brain tumors

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2820000201%2988%3A3%3C685%3A%3AAID-CNCR27%3E3.0.CO%3B2-K

21 January 2018

Identifiers

10.1002/(SICI)1097-0142(20000201)88:3<685::AID-CNCR27>3.0.CO;2-K

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/10649264

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/10649264

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53918457&oldid=1612179608"